Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model.
Wicklein D, Ramos Leal N, Salamon J, Thamer M, Herrmann H, Valent P, Schumacher U, Ullrich S
PLOS ONE. 2012;7(2):30567.

Letzte Aktualisierung aus dem FIS: 03.12.2023 - 00:34 Uhr